目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value

4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation

5 Market Outlook
5.1. Market value forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?

8 Company Profiles
8.1. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
8.2. Shanghai Kehua Bio-engineering Co Ltd
8.3. Novo Nordisk A/S
8.4. Sinovac Biotech Ltd.

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: China biotechnology industry value: $ billion, 2016-21
Table 2: China biotechnology industry category segmentation: % share, by value, 2016-2021
Table 3: China biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: China biotechnology industry geography segmentation: $ billion, 2021
Table 5: China biotechnology industry value forecast: $ billion, 2021-26
Table 6: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: key facts
Table 7: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Annual Financial Ratios
Table 8: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Key Employees
Table 9: Shanghai Kehua Bio-engineering Co Ltd: key facts
Table 10: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
Table 11: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
Table 12: Novo Nordisk A/S: key facts
Table 13: Novo Nordisk A/S: Annual Financial Ratios
Table 14: Novo Nordisk A/S: Key Employees
Table 15: Novo Nordisk A/S: Key Employees Continued
Table 16: Sinovac Biotech Ltd.: key facts
Table 17: Sinovac Biotech Ltd.: Annual Financial Ratios
Table 18: Sinovac Biotech Ltd.: Key Employees
Table 19: China size of population (million), 2017-21
Table 20: China gdp (constant 2005 prices, $ billion), 2017-21
Table 21: China gdp (current prices, $ billion), 2017-21
Table 22: China inflation, 2017-21
Table 23: China consumer price index (absolute), 2017-21
Table 24: China exchange rate, 2017-21

List of Figures
Figure 1: China biotechnology industry value: $ billion, 2016-21
Figure 2: China biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: China biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: China biotechnology industry value forecast: $ billion, 2021-26
Figure 5: Forces driving competition in the biotechnology industry in China, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in China, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in China, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in China, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in China, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in China, 2021